DOI: 10.1007/s10549-006-9242-8. REporting recommendations for tumor MARKer prognostic studies (REMARK)

REporting recommendations for tumor MARKer prognostic studies (REMARK)

10.1007/s10549-006-9242-8

Crossref journal-article

Springer Science and Business Media LLC

Breast Cancer Research and Treatment (297)

Bibliography

McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2006). REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Research and Treatment, 100(2), 229â235.

Authors 6

Lisa M. McShane (first)
Douglas G. Altman (additional)
Willi Sauerbrei (additional)
Sheila E. Taube (additional)
Massimo Gion (additional)
Gary M. Clark (additional)

References 42 Referenced 634

Hayes DF, Bast RC, Desch CE, Fritsche H Jr, Kemeny NE, Jessup JM et al (1996) Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst 88:1456–1466 (10.1093/jnci/88.20.1456) / J Natl Cancer Inst by DF Hayes (1996)
Bast RC Jr, Ravdin P, Hayes DF, Bates S, Fritsche H Jr, Jessup JM et al for the American Society of Clinical Oncology Tumor Markers Expert Panel (2001). 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1865–1878 (10.1200/JCO.2001.19.6.1865) / J Clin Oncol by RC Bast Jr (2001)
Schilsky RL, Taube SE (2002) Introduction: Tumor markers as clinical cancer tests—are we there yet? Semin Oncol 29:211–212 (10.1053/sonc.2002.32890) / Semin Oncol by RL Schilsky (2002)
McGuire WL (1991) Breast cancer prognostic factors: evaluation guidelines. J Natl Cancer Inst 83:154–155 (10.1093/jnci/83.3.154) / J Natl Cancer Inst by WL McGuire (1991)
Fielding LP, Fenoglio-Preiser CM, Freedman LS (1992) The future of prognostic factors in outcome prediction for patients with cancer. Cancer 70:2367–2377 (10.1002/1097-0142(19921101)70:9<2367::AID-CNCR2820700927>3.0.CO;2-B) / Cancer by LP Fielding (1992)
Burke HB, Henson DE (1993) Criteria for prognostic factors and for an enhanced prognostic system. Cancer 72:3131–3135 (10.1002/1097-0142(19931115)72:10<3131::AID-CNCR2820721039>3.0.CO;2-J) / Cancer by HB Burke (1993)
Concato J, Feinstein AR, Holford TR (1993) The risk of determining risk with multivariable models. Ann Intern Med 118:201–210 (10.7326/0003-4819-118-3-199302010-00009) / Ann Intern Med by J Concato (1993)
Gasparini G, Pozza F, Harris AL (1993) Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J Natl Cancer Inst 85:1206–1219 (10.1093/jnci/85.15.1206) / J Natl Cancer Inst by G Gasparini (1993)
Simon R, Altman DG (1994) Statistical aspects of prognostic factor studies in oncology. Br J Cancer 69:979–985 (10.1038/bjc.1994.192) / Br J Cancer by R Simon (1994)
Gasparini G (1998) Prognostic variables in node-negative and node-positive breast cancer. Breast Cancer Res Treat 52:321–331 (10.1023/A:1006102021879) / Breast Cancer Res Treat by G Gasparini (1998)
Hall PA, Going JJ (1999) Predicting the future: a critical appraisal of cancer prognosis studies. Histopathology 35:489–494 (10.1046/j.1365-2559.1999.00862.x) / Histopathology by PA Hall (1999)
Hoppin JA, Tolbert PE, Taylor JA, Schroeder JC, Holly EA (2002) Potential for selection bias with tumor tissue retrieval in molecular epidemiology studies. Ann Epidemiol 12:1–6 (10.1016/S1047-2797(01)00250-2) / Ann Epidemiol by JA Hoppin (2002)
Thor AD, Liu S, Moore DH II, Edgerton SM (1999) Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer. J Clin Oncol 17:470–477 (10.1200/JCO.1999.17.2.470) / J Clin Oncol by AD Thor (1999)
Gancberg D, Lespagnard L, Rouas G, Paesmans M, Piccart M, DiLeo A et al (2000) Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 cases. Am J Clin Pathol 113:675–682 (10.1309/0F58-0GRX-FK4R-A6VA) / Am J Clin Pathol by D Gancberg (2000)
McShane LM, Aamodt R Cordon-Cardo C, Cote R, Faraggi D, Fradet Y et al and the National Cancer Institute Bladder Tumor Marker Network (2000). Reproducibility of p53 immunohistochemistry in bladder tumors. Clin Cancer Res 6:1854–1864 / Clin Cancer Res by LM McShane (2000)
Paik S, Bryant J, Tan-Chiu E, Romond E, Hiller W, Park K et al (2002) Real-world performance of HER2 testing—National Surgical Adjuvant Breast and Bowel Project Experience. J Natl Cancer Inst 94:852–854 (10.1093/jnci/94.11.852) / J Natl Cancer Inst by S Paik (2002)
Roche PC, Suman VJ, Jenkins RB, Davidson NE, Martino S, Kaufman PA et al (2002) Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831. J Natl Cancer Inst 94:855–857 (10.1093/jnci/94.11.855) / J Natl Cancer Inst by PC Roche (2002)
Altman DG, De Stavola BL, Love SB, Stepniewska KA (1995) Review of survival analyses published in cancer journals. Br J Cancer 72:511–518 (10.1038/bjc.1995.364) / Br J Cancer by DG Altman (1995)
Brundage MD, Davies D, Mackillop WJ (2002) Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 122:1037–1057 (10.1378/chest.122.3.1037) / Chest by MD Brundage (2002)
Mirza AN, Mirza NQ, Vlastos G, Singletary SE (2002) Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years. Ann Surg 235:10–26 (10.1097/00000658-200201000-00003) / Ann Surg by AN Mirza (2002)
Riley RD, Abrams KR, Sutton AJ, Lambert PC, Jones DR, Heney D et al (2003) Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future. Br J Cancer 88: 1191–1198 (10.1038/sj.bjc.6600886) / Br J Cancer by RD Riley (2003)
Riley RD, Burchill SA, Abrams KR, Heney D, Sutton AJ, Jones DR et al (2003) A systematic review of molecular and biological markers in tumours of the Ewing’s sarcoma family. Eur J Cancer 39:19–30 (10.1016/S0959-8049(02)00500-2) / Eur J Cancer by RD Riley (2003)
Burton A, Altman DG (2004) Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines. Br J Cancer 91:4–8 (10.1038/sj.bjc.6601907) / Br J Cancer by A Burton (2004)
Popat S, Matakidou A, Houlston RS (2004) Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J Clin Oncol 22: 529–536 (10.1200/JCO.2004.05.064) / J Clin Oncol by S Popat (2004)
Riley RD, Heney D, Jones DR, Sutton AJ, Lambert PC, Abrams KR et al (2004) A systematic review of molecular and biological tumor markers in neuroblastoma. Clin Cancer Res 10:4–12 (10.1158/1078-0432.CCR-1051-2) / Clin Cancer Res by RD Riley (2004)
Altman DG, Lyman GH (1998) Methodological challenges in the evaluation of prognostic factors in breast cancer. Breast Cancer Res Treat 52:289–303 (10.1023/A:1006193704132) / Breast Cancer Res Treat by DG Altman (1998)
Gion M, Boracchi P, Biganzoli E, Daidone MG (1999) A guide for reviewing submitted manuscripts (and indications for the design of translational research studies on biomarkers). Int J Biol Markers 14:123–133 (10.1177/172460089901400301) / Int J Biol Markers by M Gion (1999)
Altman DG (2001) Systematic reviews of evaluations of prognostic variables. In: Egger M, Davey Smith G, Altman DG (eds) Systematic reviews in health care. Meta−analysis in context. 2nd edn. BMJ Books, London pp 228–247 (10.1002/9780470693926.ch13) / Systematic reviews in health care. Meta−analysis in context by DG Altman (2001)
Altman DG (2001) Systematic reviews of evaluations of prognostic variables. BMJ 323:224–228 (10.1136/bmj.323.7306.224) / BMJ by DG Altman (2001)
McShane LM, Simon R (2001) Statistical methods for the analysis of prognostic factor studies. In: Gospodarowicz MK, Henson DE, Hutter RVP, O’Sullivan B, Sobin LH, Wittekind Ch (eds) Prognostic factors in cancer. 2nd edn. Wiley-Liss, New York pp 37–48 / Prognostic factors in cancer by LM McShane (2001)
Simon R (2001) Evaluating prognostic factor studies. In: Gospodarowicz MK, Henson DE, Hutter RVP, O’Sullivan B, Sobin LH, Wittekind Ch (eds) Prognostic factors in cancer. 2nd edn. Wiley-Liss, New York pp 49–56 / Prognostic factors in cancer by R Simon (2001)
Biganzoli E, Boracchi P, Marubini E (2003) Biostatistics and tumor marker studies in breast cancer: design, analysis and interpretation issues. Int J Biol Markers 18:40–48 (10.1177/172460080301800107) / Int J Biol Markers by E Biganzoli (2003)
Schumacher M, Hollander N, Schwarzer G, Sauerbrei W (2006) Prognostic factor studies. In: Crowley J, Ankerst DP (eds) Handbook of statistics in clinical oncology. Boca Raton: Chapman & Hall/CRC Press, pp 289–333
Moher D, Schulz KF, Altman D for the CONSORT Group (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. JAMA 285:1987–1991 (10.1001/jama.285.15.1987)
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM et al (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 49:1–6 (10.1373/49.1.1) / Clin Chem by PM Bossuyt (2003)
Altman DG, Lausen B, Sauerbrei W, Schumacher M (1994) Dangers of using “optimal” cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86:829–835 (10.1093/jnci/86.11.829) / J Natl Cancer Inst by DG Altman (1994)
Hilsenbeck SG, Clark GM, McGuire WL (1992) Why do so many prognostic factors fail to pan out? Breast Cancer Res Treat 22:197–206 (10.1007/BF01840833) / Breast Cancer Res Treat by SG Hilsenbeck (1992)
Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup D for the QUOROM Group (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 354:1896–1900 (10.1016/S0140-6736(99)04149-5)
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008–2012 (10.1001/jama.283.15.2008) / JAMA by DF Stroup (2000)
Hammond ME, Taube SE (2002) Issues and barriers to development of clinically useful tumor markers: a development pathway proposal. Semin Oncol 29:213–221 (10.1053/sonc.2002.32896) / Semin Oncol by ME Hammond (2002)
Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D et al (2001) for the CONSORT Group. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134:663–694 (10.7326/0003-4819-134-8-200104170-00012) / Ann Intern Med by DG Altman (2001)
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM et al (2003) Standards for Reporting of Diagnostic Accuracy. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 49:7–18 (10.1373/49.1.7) / Clin Chem by PM Bossuyt (2003)

Dates

Type	When
Created	19 years ago (Aug. 23, 2006, 2:44 a.m.)
Deposited	6 years, 3 months ago (May 30, 2019, 8:28 a.m.)
Indexed	1 month, 1 week ago (July 25, 2025, 5:59 a.m.)
Issued	19 years ago (Aug. 24, 2006)
Published	19 years ago (Aug. 24, 2006)
Published Online	19 years ago (Aug. 24, 2006)
Published Print	18 years, 10 months ago (Oct. 24, 2006)

Funders 0

None

BibTeX

@article{McShane_2006, title={REporting recommendations for tumor MARKer prognostic studies (REMARK)}, volume={100}, ISSN={1573-7217}, url={http://dx.doi.org/10.1007/s10549-006-9242-8}, DOI={10.1007/s10549-006-9242-8}, number={2}, journal={Breast Cancer Research and Treatment}, publisher={Springer Science and Business Media LLC}, author={McShane, Lisa M. and Altman, Douglas G. and Sauerbrei, Willi and Taube, Sheila E. and Gion, Massimo and Clark, Gary M.}, year={2006}, month=aug, pages={229–235} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        7,
        25
      ]
    ],
    "date-time": "2025-07-25T09:59:47Z",
    "timestamp": 1753437587433
  },
  "reference-count": 42,
  "publisher": "Springer Science and Business Media LLC",
  "issue": "2",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2006,
            8,
            24
          ]
        ],
        "date-time": "2006-08-24T00:00:00Z",
        "timestamp": 1156377600000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "http://www.springer.com/tdm"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2006,
        10,
        24
      ]
    ]
  },
  "DOI": "10.1007/s10549-006-9242-8",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2006,
        8,
        23
      ]
    ],
    "date-time": "2006-08-23T06:44:20Z",
    "timestamp": 1156315460000
  },
  "page": "229-235",
  "source": "Crossref",
  "is-referenced-by-count": 634,
  "title": "REporting recommendations for tumor MARKer prognostic studies (REMARK)",
  "prefix": "10.1007",
  "volume": "100",
  "author": [
    {
      "given": "Lisa M.",
      "family": "McShane",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Douglas G.",
      "family": "Altman",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Willi",
      "family": "Sauerbrei",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Sheila E.",
      "family": "Taube",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Massimo",
      "family": "Gion",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Gary M.",
      "family": "Clark",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "297",
  "published-online": {
    "date-parts": [
      [
        2006,
        8,
        24
      ]
    ]
  },
  "reference": [
    {
      "key": "9242_CR1",
      "doi-asserted-by": "crossref",
      "first-page": "1456",
      "DOI": "10.1093/jnci/88.20.1456",
      "volume": "88",
      "author": "DF Hayes",
      "year": "1996",
      "unstructured": "Hayes DF, Bast RC, Desch CE, Fritsche H Jr, Kemeny NE, Jessup JM et al (1996) Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst 88:1456\u20131466",
      "journal-title": "J Natl Cancer Inst"
    },
    {
      "key": "9242_CR2",
      "doi-asserted-by": "crossref",
      "first-page": "1865",
      "DOI": "10.1200/JCO.2001.19.6.1865",
      "volume": "19",
      "author": "RC Bast Jr",
      "year": "2001",
      "unstructured": "Bast RC Jr, Ravdin P, Hayes DF, Bates S, Fritsche H Jr, Jessup JM et al for the American Society of Clinical Oncology Tumor Markers Expert Panel (2001). 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1865\u20131878",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "9242_CR3",
      "doi-asserted-by": "crossref",
      "first-page": "211",
      "DOI": "10.1053/sonc.2002.32890",
      "volume": "29",
      "author": "RL Schilsky",
      "year": "2002",
      "unstructured": "Schilsky RL, Taube SE (2002) Introduction: Tumor markers as clinical cancer tests\u2014are we there yet? Semin Oncol 29:211\u2013212",
      "journal-title": "Semin Oncol"
    },
    {
      "key": "9242_CR4",
      "doi-asserted-by": "crossref",
      "first-page": "154",
      "DOI": "10.1093/jnci/83.3.154",
      "volume": "83",
      "author": "WL McGuire",
      "year": "1991",
      "unstructured": "McGuire WL (1991) Breast cancer prognostic factors: evaluation guidelines. J Natl Cancer Inst 83:154\u2013155",
      "journal-title": "J Natl Cancer Inst"
    },
    {
      "key": "9242_CR5",
      "doi-asserted-by": "crossref",
      "first-page": "2367",
      "DOI": "10.1002/1097-0142(19921101)70:9<2367::AID-CNCR2820700927>3.0.CO;2-B",
      "volume": "70",
      "author": "LP Fielding",
      "year": "1992",
      "unstructured": "Fielding LP, Fenoglio-Preiser CM, Freedman LS (1992) The future of prognostic factors in outcome prediction for patients with cancer. Cancer 70:2367\u20132377",
      "journal-title": "Cancer"
    },
    {
      "key": "9242_CR6",
      "doi-asserted-by": "crossref",
      "first-page": "3131",
      "DOI": "10.1002/1097-0142(19931115)72:10<3131::AID-CNCR2820721039>3.0.CO;2-J",
      "volume": "72",
      "author": "HB Burke",
      "year": "1993",
      "unstructured": "Burke HB, Henson DE (1993) Criteria for prognostic factors and for an enhanced prognostic system. Cancer 72:3131\u20133135",
      "journal-title": "Cancer"
    },
    {
      "key": "9242_CR7",
      "doi-asserted-by": "crossref",
      "first-page": "201",
      "DOI": "10.7326/0003-4819-118-3-199302010-00009",
      "volume": "118",
      "author": "J Concato",
      "year": "1993",
      "unstructured": "Concato J, Feinstein AR, Holford TR (1993) The risk of determining risk with multivariable models. Ann Intern Med 118:201\u2013210",
      "journal-title": "Ann Intern Med"
    },
    {
      "key": "9242_CR8",
      "doi-asserted-by": "crossref",
      "first-page": "1206",
      "DOI": "10.1093/jnci/85.15.1206",
      "volume": "85",
      "author": "G Gasparini",
      "year": "1993",
      "unstructured": "Gasparini G, Pozza F, Harris AL (1993) Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J Natl Cancer Inst 85:1206\u20131219",
      "journal-title": "J Natl Cancer Inst"
    },
    {
      "key": "9242_CR9",
      "doi-asserted-by": "crossref",
      "first-page": "979",
      "DOI": "10.1038/bjc.1994.192",
      "volume": "69",
      "author": "R Simon",
      "year": "1994",
      "unstructured": "Simon R, Altman DG (1994) Statistical aspects of prognostic factor studies in oncology. Br J Cancer 69:979\u2013985",
      "journal-title": "Br J Cancer"
    },
    {
      "key": "9242_CR10",
      "doi-asserted-by": "crossref",
      "first-page": "321",
      "DOI": "10.1023/A:1006102021879",
      "volume": "52",
      "author": "G Gasparini",
      "year": "1998",
      "unstructured": "Gasparini G (1998) Prognostic variables in node-negative and node-positive breast cancer. Breast Cancer Res Treat 52:321\u2013331",
      "journal-title": "Breast Cancer Res Treat"
    },
    {
      "key": "9242_CR11",
      "doi-asserted-by": "crossref",
      "first-page": "489",
      "DOI": "10.1046/j.1365-2559.1999.00862.x",
      "volume": "35",
      "author": "PA Hall",
      "year": "1999",
      "unstructured": "Hall PA, Going JJ (1999) Predicting the future: a critical appraisal of cancer prognosis studies. Histopathology 35:489\u2013494",
      "journal-title": "Histopathology"
    },
    {
      "key": "9242_CR12",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1016/S1047-2797(01)00250-2",
      "volume": "12",
      "author": "JA Hoppin",
      "year": "2002",
      "unstructured": "Hoppin JA, Tolbert PE, Taylor JA, Schroeder JC, Holly EA (2002) Potential for selection bias with tumor tissue retrieval in molecular epidemiology studies. Ann Epidemiol 12:1\u20136",
      "journal-title": "Ann Epidemiol"
    },
    {
      "key": "9242_CR13",
      "doi-asserted-by": "crossref",
      "first-page": "470",
      "DOI": "10.1200/JCO.1999.17.2.470",
      "volume": "17",
      "author": "AD Thor",
      "year": "1999",
      "unstructured": "Thor AD, Liu S, Moore DH II, Edgerton SM (1999) Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer. J Clin Oncol 17:470\u2013477",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "9242_CR14",
      "doi-asserted-by": "crossref",
      "first-page": "675",
      "DOI": "10.1309/0F58-0GRX-FK4R-A6VA",
      "volume": "113",
      "author": "D Gancberg",
      "year": "2000",
      "unstructured": "Gancberg D, Lespagnard L, Rouas G, Paesmans M, Piccart M, DiLeo A et al (2000) Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 cases. Am J Clin Pathol 113:675\u2013682",
      "journal-title": "Am J Clin Pathol"
    },
    {
      "key": "9242_CR15",
      "first-page": "1854",
      "volume": "6",
      "author": "LM McShane",
      "year": "2000",
      "unstructured": "McShane LM, Aamodt R Cordon-Cardo C, Cote R, Faraggi D, Fradet Y et al and the National Cancer Institute Bladder Tumor Marker Network (2000). Reproducibility of p53 immunohistochemistry in bladder tumors. Clin Cancer Res 6:1854\u20131864",
      "journal-title": "Clin Cancer Res"
    },
    {
      "key": "9242_CR16",
      "doi-asserted-by": "crossref",
      "first-page": "852",
      "DOI": "10.1093/jnci/94.11.852",
      "volume": "94",
      "author": "S Paik",
      "year": "2002",
      "unstructured": "Paik S, Bryant J, Tan-Chiu E, Romond E, Hiller W, Park K et al (2002) Real-world performance of HER2 testing\u2014National Surgical Adjuvant Breast and Bowel Project Experience. J Natl Cancer Inst 94:852\u2013854",
      "journal-title": "J Natl Cancer Inst"
    },
    {
      "key": "9242_CR17",
      "doi-asserted-by": "crossref",
      "first-page": "855",
      "DOI": "10.1093/jnci/94.11.855",
      "volume": "94",
      "author": "PC Roche",
      "year": "2002",
      "unstructured": "Roche PC, Suman VJ, Jenkins RB, Davidson NE, Martino S, Kaufman PA et al (2002) Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831. J Natl Cancer Inst 94:855\u2013857",
      "journal-title": "J Natl Cancer Inst"
    },
    {
      "key": "9242_CR18",
      "doi-asserted-by": "crossref",
      "first-page": "511",
      "DOI": "10.1038/bjc.1995.364",
      "volume": "72",
      "author": "DG Altman",
      "year": "1995",
      "unstructured": "Altman DG, De Stavola BL, Love SB, Stepniewska KA (1995) Review of survival analyses published in cancer journals. Br J Cancer 72:511\u2013518",
      "journal-title": "Br J Cancer"
    },
    {
      "key": "9242_CR19",
      "doi-asserted-by": "crossref",
      "first-page": "1037",
      "DOI": "10.1378/chest.122.3.1037",
      "volume": "122",
      "author": "MD Brundage",
      "year": "2002",
      "unstructured": "Brundage MD, Davies D, Mackillop WJ (2002) Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 122:1037\u20131057",
      "journal-title": "Chest"
    },
    {
      "key": "9242_CR20",
      "doi-asserted-by": "crossref",
      "first-page": "10",
      "DOI": "10.1097/00000658-200201000-00003",
      "volume": "235",
      "author": "AN Mirza",
      "year": "2002",
      "unstructured": "Mirza AN, Mirza NQ, Vlastos G, Singletary SE (2002) Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5\u00a0years. Ann Surg 235:10\u201326",
      "journal-title": "Ann Surg"
    },
    {
      "key": "9242_CR21",
      "doi-asserted-by": "crossref",
      "first-page": "1191",
      "DOI": "10.1038/sj.bjc.6600886",
      "volume": "88",
      "author": "RD Riley",
      "year": "2003",
      "unstructured": "Riley RD, Abrams KR, Sutton AJ, Lambert PC, Jones DR, Heney D et al (2003) Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future. Br J Cancer 88: 1191\u20131198",
      "journal-title": "Br J Cancer"
    },
    {
      "key": "9242_CR22",
      "doi-asserted-by": "crossref",
      "first-page": "19",
      "DOI": "10.1016/S0959-8049(02)00500-2",
      "volume": "39",
      "author": "RD Riley",
      "year": "2003",
      "unstructured": "Riley RD, Burchill SA, Abrams KR, Heney D, Sutton AJ, Jones DR et al (2003) A systematic review of molecular and biological markers in tumours of the Ewing\u2019s sarcoma family. Eur J Cancer 39:19\u201330",
      "journal-title": "Eur J Cancer"
    },
    {
      "key": "9242_CR23",
      "doi-asserted-by": "crossref",
      "first-page": "4",
      "DOI": "10.1038/sj.bjc.6601907",
      "volume": "91",
      "author": "A Burton",
      "year": "2004",
      "unstructured": "Burton A, Altman DG (2004) Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines. Br J Cancer 91:4\u20138",
      "journal-title": "Br J Cancer"
    },
    {
      "key": "9242_CR24",
      "doi-asserted-by": "crossref",
      "first-page": "529",
      "DOI": "10.1200/JCO.2004.05.064",
      "volume": "22",
      "author": "S Popat",
      "year": "2004",
      "unstructured": "Popat S, Matakidou A, Houlston RS (2004) Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J Clin Oncol 22: 529\u2013536",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "9242_CR25",
      "doi-asserted-by": "crossref",
      "first-page": "4",
      "DOI": "10.1158/1078-0432.CCR-1051-2",
      "volume": "10",
      "author": "RD Riley",
      "year": "2004",
      "unstructured": "Riley RD, Heney D, Jones DR, Sutton AJ, Lambert PC, Abrams KR et al (2004) A systematic review of molecular and biological tumor markers in neuroblastoma. Clin Cancer Res 10:4\u201312",
      "journal-title": "Clin Cancer Res"
    },
    {
      "key": "9242_CR26",
      "doi-asserted-by": "crossref",
      "first-page": "289",
      "DOI": "10.1023/A:1006193704132",
      "volume": "52",
      "author": "DG Altman",
      "year": "1998",
      "unstructured": "Altman DG, Lyman GH (1998) Methodological challenges in the evaluation of prognostic factors in breast cancer. Breast Cancer Res Treat 52:289\u2013303",
      "journal-title": "Breast Cancer Res Treat"
    },
    {
      "key": "9242_CR27",
      "doi-asserted-by": "crossref",
      "first-page": "123",
      "DOI": "10.1177/172460089901400301",
      "volume": "14",
      "author": "M Gion",
      "year": "1999",
      "unstructured": "Gion M, Boracchi P, Biganzoli E, Daidone MG (1999) A guide for reviewing submitted manuscripts (and indications for the design of translational research studies on biomarkers). Int J Biol Markers 14:123\u2013133",
      "journal-title": "Int J Biol Markers"
    },
    {
      "key": "9242_CR28",
      "doi-asserted-by": "crossref",
      "first-page": "228",
      "DOI": "10.1002/9780470693926.ch13",
      "volume-title": "Systematic reviews in health care. Meta\u2212analysis in context",
      "author": "DG Altman",
      "year": "2001",
      "unstructured": "Altman DG (2001) Systematic reviews of evaluations of prognostic variables. In: Egger M, Davey Smith G, Altman DG (eds) Systematic reviews in health care. Meta\u2212analysis in context. 2nd edn. BMJ Books, London pp 228\u2013247",
      "edition": "2"
    },
    {
      "key": "9242_CR29",
      "doi-asserted-by": "crossref",
      "first-page": "224",
      "DOI": "10.1136/bmj.323.7306.224",
      "volume": "323",
      "author": "DG Altman",
      "year": "2001",
      "unstructured": "Altman DG (2001) Systematic reviews of evaluations of prognostic variables. BMJ 323:224\u2013228",
      "journal-title": "BMJ"
    },
    {
      "key": "9242_CR30",
      "first-page": "37",
      "volume-title": "Prognostic factors in cancer",
      "author": "LM McShane",
      "year": "2001",
      "unstructured": "McShane LM, Simon R (2001) Statistical methods for the analysis of prognostic factor studies. In: Gospodarowicz MK, Henson DE, Hutter RVP, O\u2019Sullivan B, Sobin LH, Wittekind Ch (eds) Prognostic factors in cancer. 2nd edn. Wiley-Liss, New York pp 37\u201348",
      "edition": "2"
    },
    {
      "key": "9242_CR31",
      "first-page": "49",
      "volume-title": "Prognostic factors in cancer",
      "author": "R Simon",
      "year": "2001",
      "unstructured": "Simon R (2001) Evaluating prognostic factor studies. In: Gospodarowicz MK, Henson DE, Hutter RVP, O\u2019Sullivan B, Sobin LH, Wittekind Ch (eds) Prognostic factors in cancer. 2nd edn. Wiley-Liss, New York pp 49\u201356",
      "edition": "2"
    },
    {
      "key": "9242_CR32",
      "doi-asserted-by": "crossref",
      "first-page": "40",
      "DOI": "10.1177/172460080301800107",
      "volume": "18",
      "author": "E Biganzoli",
      "year": "2003",
      "unstructured": "Biganzoli E, Boracchi P, Marubini E (2003) Biostatistics and tumor marker studies in breast cancer: design, analysis and interpretation issues. Int J Biol Markers 18:40\u201348",
      "journal-title": "Int J Biol Markers"
    },
    {
      "key": "9242_CR33",
      "unstructured": "Schumacher M, Hollander N, Schwarzer G, Sauerbrei W (2006) Prognostic factor studies. In: Crowley J, Ankerst DP (eds) Handbook of statistics in clinical oncology. Boca Raton: Chapman & Hall/CRC Press, pp 289\u2013333"
    },
    {
      "key": "9242_CR34",
      "doi-asserted-by": "crossref",
      "unstructured": "Moher D, Schulz KF, Altman D for the CONSORT Group (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. JAMA 285:1987\u20131991",
      "DOI": "10.1001/jama.285.15.1987"
    },
    {
      "key": "9242_CR35",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1373/49.1.1",
      "volume": "49",
      "author": "PM Bossuyt",
      "year": "2003",
      "unstructured": "Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM et al (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 49:1\u20136",
      "journal-title": "Clin Chem"
    },
    {
      "key": "9242_CR36",
      "doi-asserted-by": "crossref",
      "first-page": "829",
      "DOI": "10.1093/jnci/86.11.829",
      "volume": "86",
      "author": "DG Altman",
      "year": "1994",
      "unstructured": "Altman DG, Lausen B, Sauerbrei W, Schumacher M (1994) Dangers of using \u201coptimal\u201d cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86:829\u2013835",
      "journal-title": "J Natl Cancer Inst"
    },
    {
      "key": "9242_CR37",
      "doi-asserted-by": "crossref",
      "first-page": "197",
      "DOI": "10.1007/BF01840833",
      "volume": "22",
      "author": "SG Hilsenbeck",
      "year": "1992",
      "unstructured": "Hilsenbeck SG, Clark GM, McGuire WL (1992) Why do so many prognostic factors fail to pan out? Breast Cancer Res Treat 22:197\u2013206",
      "journal-title": "Breast Cancer Res Treat"
    },
    {
      "key": "9242_CR38",
      "doi-asserted-by": "crossref",
      "unstructured": "Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup D for the QUOROM Group (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 354:1896\u20131900",
      "DOI": "10.1016/S0140-6736(99)04149-5"
    },
    {
      "key": "9242_CR39",
      "doi-asserted-by": "crossref",
      "first-page": "2008",
      "DOI": "10.1001/jama.283.15.2008",
      "volume": "283",
      "author": "DF Stroup",
      "year": "2000",
      "unstructured": "Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008\u20132012",
      "journal-title": "JAMA"
    },
    {
      "key": "9242_CR40",
      "doi-asserted-by": "crossref",
      "first-page": "213",
      "DOI": "10.1053/sonc.2002.32896",
      "volume": "29",
      "author": "ME Hammond",
      "year": "2002",
      "unstructured": "Hammond ME, Taube SE (2002) Issues and barriers to development of clinically useful tumor markers: a development pathway proposal. Semin Oncol 29:213\u2013221",
      "journal-title": "Semin Oncol"
    },
    {
      "key": "9242_CR41",
      "doi-asserted-by": "crossref",
      "first-page": "663",
      "DOI": "10.7326/0003-4819-134-8-200104170-00012",
      "volume": "134",
      "author": "DG Altman",
      "year": "2001",
      "unstructured": "Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D et al (2001) for the CONSORT Group. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134:663\u2013694",
      "journal-title": "Ann Intern Med"
    },
    {
      "key": "9242_CR42",
      "doi-asserted-by": "crossref",
      "first-page": "7",
      "DOI": "10.1373/49.1.7",
      "volume": "49",
      "author": "PM Bossuyt",
      "year": "2003",
      "unstructured": "Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM et al (2003) Standards for Reporting of Diagnostic Accuracy. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 49:7\u201318",
      "journal-title": "Clin Chem"
    }
  ],
  "container-title": "Breast Cancer Research and Treatment",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10549-006-9242-8.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10549-006-9242-8/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10549-006-9242-8",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T12:28:41Z",
    "timestamp": 1559219321000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10549-006-9242-8"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2006,
        8,
        24
      ]
    ]
  },
  "references-count": 42,
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2006,
          10,
          24
        ]
      ]
    }
  },
  "alternative-id": [
    "9242"
  ],
  "URL": "http://dx.doi.org/10.1007/s10549-006-9242-8",
  "relation": {},
  "ISSN": [
    "0167-6806",
    "1573-7217"
  ],
  "subject": [],
  "container-title-short": "Breast Cancer Res Treat",
  "published": {
    "date-parts": [
      [
        2006,
        8,
        24
      ]
    ]
  }
}